The high cost of prescription drugs: causes and solutions
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Global spending on prescription drugs in 2020 is expected to be ~$1.3 trillion; the United States alone will spend ~$350 billion 1 . These high spending rates are expected to increase at a rate of 3–6% annually worldwide. The magnitude of increase is even more alarming for cancer treatments that account for a large proportion of prescription drug costs. In 2018, global spending on cancer treatments was approximately 150 billion, and has increased by >10% in each of the past 5 years 2 .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Innovation in the pharmaceutical industry: New estimates of R&D costs
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.01.012 · Cited by 3,359
Cited by
Multistep enzyme cascades as a route towards green and sustainable pharmaceutical syntheses
Benítez-Mateos, A. I., Roura Padrosa, D., & Paradisi, F. (2022) · Nature Chemistry · doi:10.1038/s41557-022-00931-2 · Cited by 331
Lou, B., & Wu, L. (2021) · MIS Quarterly · doi:10.25300/misq/2021/16565 · Cited by 177
“Research has shown that discovering drug candidates aimed at novel therapies that represent big leaps is much harder than discovering therapies offering incremental improvements (“follow-on” drugs) (Rajkumar 2020).”
Off-Label Use vs Off-Label Marketing of Drugs
Van Norman, G. A. (2023) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2022.12.011 · Cited by 49
Metadata
- Authors
- Vincent Rajkumar, S.
- Venue
- Blood Cancer Journal
- Published
- 2020-06-23
- Volume
- 10
- Issue
- 6
- Pages
- 71-71
- ISSN
- 2044-5385 (ISSN-L)
- OpenAlex
- W3036447492
- Cited by
- 160
- References
- 1
- FWCI
- 18.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The high cost of prescription drugs: causes and solutions. https://app.cochat.ai/papers/10.1038/s41408-020-0338-x
- The paper
- Vincent Rajkumar, S. (2020). The high cost of prescription drugs: causes and solutions. Blood Cancer Journal. https://doi.org/10.1038/s41408-020-0338-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.